Hydrogels in endovascular embolization. II. Clinical use of spherical particles
In this study we report the results of clinical experiments, obtained with spherical particles made from poly(2-hydroxyethyl methacrylate) used in the embolization of arteriovenous anastomoses, in the suppression of pulmonary haemorrhage and haemoptysis and in the occlusion of some other arteries. S...
Gespeichert in:
| Veröffentlicht in: | Biomaterials 1986-11, Vol.7 (6), p.467-470 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 470 |
|---|---|
| container_issue | 6 |
| container_start_page | 467 |
| container_title | Biomaterials |
| container_volume | 7 |
| creator | Horák, Daniel šeksvec, Franti Kálal, Jaroslav Adamyan, Arnold A. Volynskii, Yurii D. Voronkova, Olga S. Kokov, Leonid S. Gumargalieva, Klara Z. |
| description | In this study we report the results of clinical experiments, obtained with spherical particles made from poly(2-hydroxyethyl methacrylate) used in the embolization of arteriovenous anastomoses, in the suppression of pulmonary haemorrhage and haemoptysis and in the occlusion of some other arteries. So far we have used these particles in the treatment of 187 patients. It must be stressed that the advantage of spherical particles consists in the simplicity of their introduction into the blood vessel through a catheter, while in the blood vessel itself the particle swells in blood still more, when compared with the particle size in saline. This results in an immediate and permanent haemostatic effect. No revascularization occurs. |
| doi_str_mv | 10.1016/0142-9612(86)90037-2 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77201697</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0142961286900372</els_id><sourcerecordid>77201697</sourcerecordid><originalsourceid>FETCH-LOGICAL-c272t-8a34a661854733f92d6347b1b15f7c7f877684e1823186387e34e9286e4ebdc53</originalsourceid><addsrcrecordid>eNp9kEtLxDAQx4Mouj6-gUJPooeueTVJL4IsPhYW9qLnkKZTjaTNmrQL66e36y4ePQ0z_8fAD6FLgqcEE3GHCad5KQi9UeK2xJjJnB6gCVFS5UWJi0M0-bOcoNOUPvG4Y06P0TGTJRZSTdDyZVPH8A4-Za7LoKvD2iQ7eBMzaKvg3bfpXeim2Xw-zWbedc4anw0JstBkafUB8fewMrF31kM6R0eN8Qku9vMMvT09vs5e8sXyeT57WOSWStrnyjBuhCCq4JKxpqS1YFxWpCJFI61slJRCcSCKMqIEUxIYh5IqARyq2hbsDF3velcxfA2Qet26ZMF700EYkpaSjoxKORr5zmhjSClCo1fRtSZuNMF6y1FvIektJK2E_uWo6Ri72vcPVQv1X2gPbtTvd_pIDtYOok7WQWehdhFsr-vg_n_wA0TxgGE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>77201697</pqid></control><display><type>article</type><title>Hydrogels in endovascular embolization. II. Clinical use of spherical particles</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Horák, Daniel ; šeksvec, Franti ; Kálal, Jaroslav ; Adamyan, Arnold A. ; Volynskii, Yurii D. ; Voronkova, Olga S. ; Kokov, Leonid S. ; Gumargalieva, Klara Z.</creator><creatorcontrib>Horák, Daniel ; šeksvec, Franti ; Kálal, Jaroslav ; Adamyan, Arnold A. ; Volynskii, Yurii D. ; Voronkova, Olga S. ; Kokov, Leonid S. ; Gumargalieva, Klara Z.</creatorcontrib><description>In this study we report the results of clinical experiments, obtained with spherical particles made from poly(2-hydroxyethyl methacrylate) used in the embolization of arteriovenous anastomoses, in the suppression of pulmonary haemorrhage and haemoptysis and in the occlusion of some other arteries. So far we have used these particles in the treatment of 187 patients. It must be stressed that the advantage of spherical particles consists in the simplicity of their introduction into the blood vessel through a catheter, while in the blood vessel itself the particle swells in blood still more, when compared with the particle size in saline. This results in an immediate and permanent haemostatic effect. No revascularization occurs.</description><identifier>ISSN: 0142-9612</identifier><identifier>EISSN: 1878-5905</identifier><identifier>DOI: 10.1016/0142-9612(86)90037-2</identifier><identifier>PMID: 3790678</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>biocompatibility ; Embolization, Therapeutic - instrumentation ; embolus ; endovascular occlusion ; Gels ; Hemorrhage - therapy ; Humans ; hydrogel ; Lung Diseases - diagnostic imaging ; Lung Diseases - therapy ; poly(2-hydroxyethyl methacrylatej ; Polyhydroxyethyl Methacrylate - therapeutic use ; Polymers ; Polymethacrylic Acids - therapeutic use ; Radiography ; thrombocytes ; Time Factors</subject><ispartof>Biomaterials, 1986-11, Vol.7 (6), p.467-470</ispartof><rights>1986</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c272t-8a34a661854733f92d6347b1b15f7c7f877684e1823186387e34e9286e4ebdc53</citedby><cites>FETCH-LOGICAL-c272t-8a34a661854733f92d6347b1b15f7c7f877684e1823186387e34e9286e4ebdc53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/0142961286900372$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/3790678$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Horák, Daniel</creatorcontrib><creatorcontrib>šeksvec, Franti</creatorcontrib><creatorcontrib>Kálal, Jaroslav</creatorcontrib><creatorcontrib>Adamyan, Arnold A.</creatorcontrib><creatorcontrib>Volynskii, Yurii D.</creatorcontrib><creatorcontrib>Voronkova, Olga S.</creatorcontrib><creatorcontrib>Kokov, Leonid S.</creatorcontrib><creatorcontrib>Gumargalieva, Klara Z.</creatorcontrib><title>Hydrogels in endovascular embolization. II. Clinical use of spherical particles</title><title>Biomaterials</title><addtitle>Biomaterials</addtitle><description>In this study we report the results of clinical experiments, obtained with spherical particles made from poly(2-hydroxyethyl methacrylate) used in the embolization of arteriovenous anastomoses, in the suppression of pulmonary haemorrhage and haemoptysis and in the occlusion of some other arteries. So far we have used these particles in the treatment of 187 patients. It must be stressed that the advantage of spherical particles consists in the simplicity of their introduction into the blood vessel through a catheter, while in the blood vessel itself the particle swells in blood still more, when compared with the particle size in saline. This results in an immediate and permanent haemostatic effect. No revascularization occurs.</description><subject>biocompatibility</subject><subject>Embolization, Therapeutic - instrumentation</subject><subject>embolus</subject><subject>endovascular occlusion</subject><subject>Gels</subject><subject>Hemorrhage - therapy</subject><subject>Humans</subject><subject>hydrogel</subject><subject>Lung Diseases - diagnostic imaging</subject><subject>Lung Diseases - therapy</subject><subject>poly(2-hydroxyethyl methacrylatej</subject><subject>Polyhydroxyethyl Methacrylate - therapeutic use</subject><subject>Polymers</subject><subject>Polymethacrylic Acids - therapeutic use</subject><subject>Radiography</subject><subject>thrombocytes</subject><subject>Time Factors</subject><issn>0142-9612</issn><issn>1878-5905</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1986</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kEtLxDAQx4Mouj6-gUJPooeueTVJL4IsPhYW9qLnkKZTjaTNmrQL66e36y4ePQ0z_8fAD6FLgqcEE3GHCad5KQi9UeK2xJjJnB6gCVFS5UWJi0M0-bOcoNOUPvG4Y06P0TGTJRZSTdDyZVPH8A4-Za7LoKvD2iQ7eBMzaKvg3bfpXeim2Xw-zWbedc4anw0JstBkafUB8fewMrF31kM6R0eN8Qku9vMMvT09vs5e8sXyeT57WOSWStrnyjBuhCCq4JKxpqS1YFxWpCJFI61slJRCcSCKMqIEUxIYh5IqARyq2hbsDF3velcxfA2Qet26ZMF700EYkpaSjoxKORr5zmhjSClCo1fRtSZuNMF6y1FvIektJK2E_uWo6Ri72vcPVQv1X2gPbtTvd_pIDtYOok7WQWehdhFsr-vg_n_wA0TxgGE</recordid><startdate>198611</startdate><enddate>198611</enddate><creator>Horák, Daniel</creator><creator>šeksvec, Franti</creator><creator>Kálal, Jaroslav</creator><creator>Adamyan, Arnold A.</creator><creator>Volynskii, Yurii D.</creator><creator>Voronkova, Olga S.</creator><creator>Kokov, Leonid S.</creator><creator>Gumargalieva, Klara Z.</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>198611</creationdate><title>Hydrogels in endovascular embolization. II. Clinical use of spherical particles</title><author>Horák, Daniel ; šeksvec, Franti ; Kálal, Jaroslav ; Adamyan, Arnold A. ; Volynskii, Yurii D. ; Voronkova, Olga S. ; Kokov, Leonid S. ; Gumargalieva, Klara Z.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c272t-8a34a661854733f92d6347b1b15f7c7f877684e1823186387e34e9286e4ebdc53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1986</creationdate><topic>biocompatibility</topic><topic>Embolization, Therapeutic - instrumentation</topic><topic>embolus</topic><topic>endovascular occlusion</topic><topic>Gels</topic><topic>Hemorrhage - therapy</topic><topic>Humans</topic><topic>hydrogel</topic><topic>Lung Diseases - diagnostic imaging</topic><topic>Lung Diseases - therapy</topic><topic>poly(2-hydroxyethyl methacrylatej</topic><topic>Polyhydroxyethyl Methacrylate - therapeutic use</topic><topic>Polymers</topic><topic>Polymethacrylic Acids - therapeutic use</topic><topic>Radiography</topic><topic>thrombocytes</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Horák, Daniel</creatorcontrib><creatorcontrib>šeksvec, Franti</creatorcontrib><creatorcontrib>Kálal, Jaroslav</creatorcontrib><creatorcontrib>Adamyan, Arnold A.</creatorcontrib><creatorcontrib>Volynskii, Yurii D.</creatorcontrib><creatorcontrib>Voronkova, Olga S.</creatorcontrib><creatorcontrib>Kokov, Leonid S.</creatorcontrib><creatorcontrib>Gumargalieva, Klara Z.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Biomaterials</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Horák, Daniel</au><au>šeksvec, Franti</au><au>Kálal, Jaroslav</au><au>Adamyan, Arnold A.</au><au>Volynskii, Yurii D.</au><au>Voronkova, Olga S.</au><au>Kokov, Leonid S.</au><au>Gumargalieva, Klara Z.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hydrogels in endovascular embolization. II. Clinical use of spherical particles</atitle><jtitle>Biomaterials</jtitle><addtitle>Biomaterials</addtitle><date>1986-11</date><risdate>1986</risdate><volume>7</volume><issue>6</issue><spage>467</spage><epage>470</epage><pages>467-470</pages><issn>0142-9612</issn><eissn>1878-5905</eissn><abstract>In this study we report the results of clinical experiments, obtained with spherical particles made from poly(2-hydroxyethyl methacrylate) used in the embolization of arteriovenous anastomoses, in the suppression of pulmonary haemorrhage and haemoptysis and in the occlusion of some other arteries. So far we have used these particles in the treatment of 187 patients. It must be stressed that the advantage of spherical particles consists in the simplicity of their introduction into the blood vessel through a catheter, while in the blood vessel itself the particle swells in blood still more, when compared with the particle size in saline. This results in an immediate and permanent haemostatic effect. No revascularization occurs.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>3790678</pmid><doi>10.1016/0142-9612(86)90037-2</doi><tpages>4</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0142-9612 |
| ispartof | Biomaterials, 1986-11, Vol.7 (6), p.467-470 |
| issn | 0142-9612 1878-5905 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_77201697 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | biocompatibility Embolization, Therapeutic - instrumentation embolus endovascular occlusion Gels Hemorrhage - therapy Humans hydrogel Lung Diseases - diagnostic imaging Lung Diseases - therapy poly(2-hydroxyethyl methacrylatej Polyhydroxyethyl Methacrylate - therapeutic use Polymers Polymethacrylic Acids - therapeutic use Radiography thrombocytes Time Factors |
| title | Hydrogels in endovascular embolization. II. Clinical use of spherical particles |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T23%3A06%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hydrogels%20in%20endovascular%20embolization.%20II.%20Clinical%20use%20of%20spherical%20particles&rft.jtitle=Biomaterials&rft.au=Hor%C3%A1k,%20Daniel&rft.date=1986-11&rft.volume=7&rft.issue=6&rft.spage=467&rft.epage=470&rft.pages=467-470&rft.issn=0142-9612&rft.eissn=1878-5905&rft_id=info:doi/10.1016/0142-9612(86)90037-2&rft_dat=%3Cproquest_cross%3E77201697%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=77201697&rft_id=info:pmid/3790678&rft_els_id=0142961286900372&rfr_iscdi=true |